Varex Imaging Corporation (VREX)

AI-powered earnings prediction for Varex Imaging Corporation (VREX).

13.59
-1.16%
USD, 2 days ago
Market Cap
571.57M
Google

Company Overview

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.

Sector
Healthcare
Industry
Medical Devices
Phone
801 972 5000
Headquarters
1678 S. Pioneer Road
Salt Lake City, UT, 84104
United States
Full-Time Employees
2,400

Key Metrics

Forward P/E
13.37
Price to Book
1.20
Beta
0.88
Profit Margin
-7.92%
Gross Margin
34.15%
Return on Equity
-12.90%
Return on Assets
3.62%
Earnings Growth
N/A
Revenue Growth
4.90%

Financial Health

Total Cash
$125.60M
Total Debt
$401.30M
Debt to Equity
81.76
Current Ratio
3.89
Free Cash Flow
$-15687500.00
Operating Cash Flow
$16.10M

Analyst Recommendations

Target Price (Mean)
$18.40
Target High
$22.00
Target Low
$16.00
Recommendation
buy
Analyst Coverage
5 Analysts

Trading Ideas

Related Stocks